Alnylam Pharmaceuticals, Inc.

BANK OF NOVA SCOTIA ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

7,749

Value ($000)

3,081

Weight

0.0%

2020 Q2 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,081	0.0%	7,749	12/31/2025
2025 Q3	11/14/2025	2,710	0.0%	5,944	9/30/2025
2025 Q2	8/13/2025	874	0.0%	2,679	6/30/2025
2025 Q1	7/2/2025	1,217	0.0%	4,506	3/31/2025
2024 Q4	7/2/2025	1,062	0.0%	4,512	12/31/2024
2024 Q3	11/13/2024	1,783	0.0%	6,483	9/30/2024
2024 Q2	8/14/2024	1,612	0.0%	6,634	6/30/2024
2024 Q1	5/15/2024	1,997	0.0%	13,363	3/31/2024
2023 Q4	2/12/2024	1,153	0.0%	6,025	12/31/2023
2023 Q3	11/14/2023	522	0.0%	2,948	9/30/2023
2023 Q2	8/3/2023	473	0.0%	2,491	6/30/2023
2023 Q1	5/11/2023	651	0.0%	3,251	3/31/2023
2022 Q4	2/9/2023	1,048	0.0%	4,411	12/31/2022
2022 Q3	11/10/2022	682	0.0%	3,407	9/30/2022
2022 Q2	8/11/2022	378	0.0%	2,594	6/30/2022
2022 Q1	5/9/2022	1,170	0.0%	7,163	3/31/2022
2021 Q4	2/11/2022	249	0.0%	1,464	12/31/2021
2021 Q1	5/6/2021	439	0.0%	3,110	3/31/2021
2020 Q4	2/11/2021	572	0.0%	4,401	12/31/2020
2020 Q3	11/12/2020	620	0.0%	4,255	9/30/2020
2020 Q2	8/11/2020	554	0.0%	3,740	6/30/2020